CRM observes the Conditional Movement Control Order (CMCO) implemented in Selangor, Wilayah Persekutuan Kuala Lumpur, Putrajaya (effective 14th October) and Sabah (effective 13th October).
- Clinical Research Malaysian organises Industry Dialogue & Investigator Dialogue annually.
- CRM Industry Dialogue provides an avenue for Pharmaceutical companies (sponsors) and CROs to directly convey any issues, suggestions or opinions that they may have to CRM. Besides strengthening cooperation and networking between all parties, CRM also takes the opportunity to update the clinical research industry on local laws, guidelines and regulations. By bringing together these industry players, CRM uses this platform to connect with them and provide updates on its current and future activities.
- CRM Investigator Dialogue is platform for Malaysian investigators conducting sponsored clinical research to discuss relevant matters with CRM. Representatives from Institute for Clinical Research as well as Clinical Research Network also participate in this program which has updates by the regulatory authority, ethics committee as well as the industry.
